Biobanking & disease registers
Disease registers and biobanks permit detailed phenotyping for clinical and biological studies.
Disease registers enable the analysis of detailed clinical information for retrospective and prospective studies on epidemiology, clinical course, outcome and treatment. Linked DNA, blood plasma and/or cerebrospinal fluid biobanks provide opportunities to study genetics and biomarkers.
|Cognitive disorders||Suvankar Pal|
|Intracerebral haemorrhage||Rustam Al-Shahi Salman|
|BRAINS (Brain Images of Normal Subjects)||Joanna Wardlaw and Susan Shenkin (Associate Member)|
|Fragile X Syndrome||Andrew Stanfield|
|Stroke||Cathie Sudlow (Associate Member)|
|Motor neurone disease||Siddharthan Chandran & Suvankar Pal|
Professor Cathie Sudlow is the Chief Scientist of UK Biobank. Within CCBS, she leads the UK Biobank Data Linkage & Outcomes Adjudication team.
UK Biobank is a major national health resource with the aim of improving the prevention, diagnosis and treatment of a wide range of serious and life-threatening illnesses - including cancer, heart diseases, stroke, diabetes, arthritis, osteoporosis, eye disorders, depression and forms of dementia.
Generation Scotland is a rich resource of high-quality, ethically consented samples and data for genetic and health related research.It is a collaboration between the Scottish University Medical Schools and NHS Scotland, and is administered by the Institute of Genetics and Molecular Medicine, University of Edinburgh. Many projects in CCBS have used the Generation Scotland resources, particularly those focused on psychiatric disorders.